CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,653 | +20.2% | 8,576 | -1.8% | 0.00% | – |
| Q2 2023 | $194,310 | +16.4% | 8,733 | +13.3% | 0.00% | – |
| Q1 2023 | $166,956 | -10.4% | 7,708 | -16.0% | 0.00% | – |
| Q4 2022 | $186,304 | -18.3% | 9,173 | +2.6% | 0.00% | – |
| Q3 2022 | $228,000 | +35.7% | 8,942 | +25.9% | 0.00% | – |
| Q2 2022 | $168,000 | +9.1% | 7,105 | +4.4% | 0.00% | – |
| Q1 2022 | $154,000 | +22.2% | 6,807 | +6.3% | 0.00% | – |
| Q4 2021 | $126,000 | -9.4% | 6,401 | -9.0% | 0.00% | – |
| Q3 2021 | $139,000 | +4.5% | 7,036 | +16.4% | 0.00% | – |
| Q2 2021 | $133,000 | -15.8% | 6,044 | -8.2% | 0.00% | – |
| Q1 2021 | $158,000 | -7.1% | 6,584 | +1.4% | 0.00% | – |
| Q4 2020 | $170,000 | +61.9% | 6,495 | +6.6% | 0.00% | – |
| Q3 2020 | $105,000 | 0.0% | 6,093 | -3.5% | 0.00% | – |
| Q2 2020 | $105,000 | +50.0% | 6,315 | +7.1% | 0.00% | – |
| Q1 2020 | $70,000 | -34.0% | 5,896 | -33.3% | 0.00% | – |
| Q4 2019 | $106,000 | -94.0% | 8,834 | -93.0% | 0.00% | -100.0% |
| Q3 2019 | $1,773,000 | -2.0% | 125,551 | -22.7% | 0.00% | 0.0% |
| Q2 2019 | $1,810,000 | -26.7% | 162,434 | -22.8% | 0.00% | 0.0% |
| Q1 2019 | $2,470,000 | -60.2% | 210,521 | -54.7% | 0.00% | -71.4% |
| Q4 2018 | $6,203,000 | +5864.4% | 464,312 | +6144.1% | 0.01% | – |
| Q3 2018 | $104,000 | -91.2% | 7,436 | -90.1% | 0.00% | -100.0% |
| Q2 2018 | $1,179,000 | -0.5% | 75,030 | +4.2% | 0.00% | 0.0% |
| Q1 2018 | $1,185,000 | -77.0% | 72,014 | -74.8% | 0.00% | -80.0% |
| Q4 2017 | $5,152,000 | -12.5% | 285,365 | -6.5% | 0.01% | -16.7% |
| Q3 2017 | $5,891,000 | +4978.4% | 305,179 | +3002.4% | 0.01% | – |
| Q2 2017 | $116,000 | +61.1% | 9,837 | +52.6% | 0.00% | – |
| Q1 2017 | $72,000 | +3500.0% | 6,447 | +1402.8% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 429 | -3.6% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 445 | +3.5% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 430 | 0.0% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 430 | +3.4% | 0.00% | – |
| Q2 2015 | $3,000 | +50.0% | 416 | +41.0% | 0.00% | – |
| Q1 2015 | $2,000 | – | 295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |